Market Overview

UPDATE: Credit Suisse Reiterates Outperform Rating, Lowers PT on Express Scripts Holding Company

Share:
Related ESRX
Express Scripts Margins Could Face Downward Pressure From Less Prescription Growth
Watch These 7 Huge Call Purchases In Tuesday Trade
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2016 Update (Seeking Alpha)

In a report published Wednesday, Credit Suisse reiterated its Outperform rating on Express Scripts Holding Company (NASDAQ: ESRX), but lowered its price target from $68.00 to $65.00.

Credit Suisse noted, “Following lower than expected initial comments regarding the 2013 economic and environmental outlook we believe the stock will find an intermediate-term home in the mid-$50 range. We believe that investors will look to grow comfortable with the industry's fundamentals and assess the potential conservatism of management's view on the economy & volumes before shares can move meaningfully higher. While we continue to struggle somewhat to reconcile ESRX's view of the market with the commentary from the company's main competitors and other supply chain peers, we continue to remain bullish on the intermediate-term opportunity for shares given the generic outlook, accretion from the deal synergies, and the strong cash flow characteristics of the business model.”

Express Scripts Holding Company closed on Tuesday at $55.18.

Latest Ratings for ESRX

DateFirmActionFromTo
Jul 2016BarclaysMaintainsOverweight
Jun 2016Morgan StanleyDowngradesUnderweight
Jun 2016BernsteinInitiates Coverage onUnderperform

View More Analyst Ratings for ESRX
View the Latest Analyst Ratings

Posted-In: Credit SuisseAnalyst Color Price Target Analyst Ratings

 

Related Articles (ESRX)

View Comments and Join the Discussion!